The official blog of the Lung Institute.

Raising Men’s Health Awareness on Lung Disease in 2015

14 Jun 2015
| Under COPD, Emphysema, Lung Disease | Posted by | 0 Comments
Raising Men's Awareness on Lung Disease in 2015

Men’s Health Week

Recognizing and preventing men’s health problems is not just a man’s issue. Because of its impact on wives, mothers, daughters, and sisters, men’s health is truly a family issue.” – Congressman Bill Richardson

For many years, it has been assumed that men are primary targets for chronic obstructive pulmonary disease (COPD). COPD is an umbrella term that is used to encompass debilitating lung diseases such as chronic bronchitis and emphysema. These conditions often leave sufferers struggling to breathe. Previous research and statistics have supported the notion that lung disease is primarily a man’s disease, and while new studies show an increase in the number of women suffering from these conditions, men must still take precautions to limit their chances of developing a chronic lung disease.

Men’s Health Week runs from June 15th through the 21st this year, which gives individuals around the globe a chance to improve their health and wellness. According to the US Men’s Health Week website, “The goal of Men’s Health Week is to heighten the awareness of preventable health problems and encourage early detection and treatment of disease among men and boys.” This year, among others, the Lung Institute team encourages people to talk about the dangers of lung disease.

7 Fast Facts about Lung Disease in Men

  1. COPD is the third leading cause of death in the United States.
  2. Smoking is the number one cause of COPD; it is also the number one preventable cause of death in the US.
  3. Male smokers are nearly 12 times as likely to die from COPD as men who have never smoked.
  4. Historically, men have been more likely than women to receive a diagnosis of emphysema.
  5. In 2011, 3.3 million men (29.6 per 1,000 population) had a diagnosis of chronic bronchitis.
  6. Middle-aged and older adults are most likely to be diagnosed with COPD. Worldwide, COPD affects men and women equally.
  7. Around 19 percent of COPD cases are attributed to occupational lung disease, which affects men more often due to occupational gender norms.

Individuals suffering from a chronic lung disease like COPD or emphysema finally have the options they so desperately need with stem cell therapy. For more information, contact us at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.